Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anthracyclines, HER2, and TOP2A: the verdict.

× No keyword cloud information.

4 in total

1. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.

Authors: Shiwei Deng; Tiandong Yan; Teodora Nikolova; Dominik Fuhrmann; Andrea Nemecek; Ute Gödtel-Armbrust; Bernd Kaina; Leszek Wojnowski
Journal: Br J Pharmacol Date: 2015-02-27 Impact factor: 8.739

Review 2. Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?

Authors: Ami N Shah; William J Gradishar
Journal: Oncologist Date: 2018-08-17

3. Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.

Authors: Shiwei Deng; Tiandong Yan; Cathleen Jendrny; Andrea Nemecek; Mladen Vincetic; Ute Gödtel-Armbrust; Leszek Wojnowski
Journal: BMC Cancer Date: 2014-11-18 Impact factor: 4.430

4. Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.

Authors: George Fountzilas; Urania Dafni; Mattheos Bobos; Vassiliki Kotoula; Anna Batistatou; Ioannis Xanthakis; Christos Papadimitriou; Ioannis Kostopoulos; Triantafillia Koletsa; Eleftheria Tsolaki; Despina Televantou; Eleni Timotheadou; Angelos Koutras; George Klouvas; Epaminontas Samantas; Nikolaos Pisanidis; Charisios Karanikiotis; Ioanna Sfakianaki; Nicholas Pavlidis; Helen Gogas; Helena Linardou; Konstantine T Kalogeras; Dimitrios Pectasides; Meletios A Dimopoulos
Journal: BMC Cancer Date: 2013-03-28 Impact factor: 4.430

4 in total